Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05430230 · ClinicalTrials.gov registry record · Phase 4
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
A Phase 4 study of Osteoarthritis, Knee, sponsored by Northwestern University.
- Active
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05430230 is a Phase 4 study of Osteoarthritis, Knee that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 20 participants, below the 580-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05430230, a Phase 4 study of Osteoarthritis, Knee, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study with a 4-period double-cross-over design evaluating a treatment with non-steroidal anti-inflammatory drugs (NSAIDs) in people with painful knee osteoarthritis.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Naproxen 500 Mg
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-08-24 |
| Est. Completion | 2027-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05430230
The ClinicalTrials.gov registry entry for NCT05430230 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 580-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (97% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05430230 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05430230 about?
NCT05430230 is a clinical study titled "Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis". This is a pilot study with a 4-period double-cross-over design evaluating a treatment with non-steroidal anti-inflammatory drugs (NSAIDs) in people with painful knee osteoarthritis.
What is the current status of trial NCT05430230?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2022-08-24. Estimated completion is 2027-09-01.
What conditions does trial NCT05430230 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT05430230?
The interventions under investigation include: Placebo (DRUG), Naproxen 500 Mg (DRUG).
Who is sponsoring clinical trial NCT05430230?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05430230 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Triamcinolone Ketorolac (TriKe) Knee Trial
RECRUITING · Phase 4
-
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes
RECRUITING · Phase 4
-
ZYNRELEF for Pain Management in Total Knee Arthroplasty
RECRUITING · Phase 4
-
Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty
RECRUITING · Phase 4
-
Corticosteroid Meniscectomy Randomized Trial
ACTIVE NOT RECRUITING · Phase 4
-
Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.